Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1.
Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1.
复制标题
丙酮酸激酶 M2 通过磷酸化 AKT1S1 激活 mTORC1。
DOI:
10.1038/srep21524
复制
发表时间:
2016-02-15
影响因子:
4.6
通讯作者:
Xu W
中科院分区:
文献类型:
--
作者:
He CL;Bian YY;Xue Y;Liu ZX;Zhou KQ;Yao CF;Lin Y;Zou HF;Luo FX;Qu YY;Zhao JY;Ye ML;Zhao SM;Xu W
In cancer cells, the mammalian target of rapamycin complex 1 (mTORC1) that requires hormonal and nutrient signals for its activation, is constitutively activated. We found that overexpression of pyruvate kinase M2 (PKM2) activates mTORC1 signaling through phosphorylating mTORC1 inhibitor AKT1 substrate 1 (AKT1S1). An unbiased quantitative phosphoproteomic survey identified 974 PKM2 substrates, including serine202 and serine203 (S202/203) of AKT1S1, in the proteome of renal cell carcinoma (RCC). Phosphorylation of S202/203 of AKT1S1 by PKM2 released AKT1S1 from raptor and facilitated its binding to 14-3-3, resulted in hormonal- and nutrient-signals independent activation of mTORC1 signaling and led accelerated oncogenic growth and autophagy inhibition in cancer cells. Decreasing S202/203 phosphorylation by TEPP-46 treatment reversed these effects. In RCCs and breast cancers, PKM2 overexpression was correlated with elevated S202/203 phosphorylation, activated mTORC1 and inhibited autophagy. Our results provided the first phosphorylome of PKM2 and revealed a constitutive mTORC1 activating mechanism in cancer cells.